“We started out 2025 with an environment that was rife with myths and disinformation," said Robert H. Hopkins, Jr., MD, in this year-end recap of 2025 and the pediatric vaccine landscape. Pediatric ...

"The FDA is taking action to make parents and doctors aware of a considerable body of evidence about potential risks associated with acetaminophen. Even with this body of evidence, the choice still ...

The FDA has approved an additional indication for Incyte's ruxolitinib cream to include pediatric patients. On September 18, 2025, the FDA approved an expanded indication of Incyte's ruxolitinib ...

The BLA for clesrovimab was based on results demonstrated in the phase 2b/3 CLEVER trial among healthy pre-term and full-term infants. On June 9, 2025, the FDA approved Merck's monoclonal antibody ...

The combination therapy yielded boosted treatment benefits of navepegritide, including improvement in mean ACH Z-score and mean annualized growth. Positive, interim data from the phase 2 COACH trial ...

RFK Jr. stated he "couldn't be more pleased" to announce that COVID-19 vaccination among healthy children and pregnant women has been removed from CDC's immunization schedule. "I couldn't be more ...

Safety, phosphate level gains, and immunogenicity data offer encouraging signals in the pivotal trial. Inozyme Pharma has announced interim results from its phase 3 ENERGY 3 trial evaluating INZ-701 ...

Early identification of autism spectrum disorder (ASD) is essential when it comes to giving children the best possible opportunities to thrive as they grow. Early diagnosis and subsequent intervention ...

The World Bank Group reports that as this global health emergency escalates, devastating impacts on health and well-being will also accelerate. All aspects of health are affected by climate change, ...

Discover mental health screening tools for the pediatric primary care provider. The National Association of Pediatric Nurse Practitioners called to prioritize integrating pediatric mental health into ...

Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP, highlighted key updates on influenza, COVID-19, and RSV vaccines at the 2025 NAPNAP National Conference. At the 2025 NAPNAP National Conference on ...

The newly-approved indication is for children aged 4 years and older who weigh 33 < 66 lbs, expanding on the August 9, 2024 approval in children at least 66 lbs. As of March 5, 2025, epinephrine nasal ...